InvestorsHub Logo
Followers 35
Posts 2620
Boards Moderated 0
Alias Born 01/02/2003

Re: sukus post# 700055

Friday, 06/21/2024 10:32:30 AM

Friday, June 21, 2024 10:32:30 AM

Post# of 732860
In what looks like could be Roswell’s mission statement or at least a Major goal is turning cold tumors hot. Roswell says both turning cold tumors hot and changing the tumor micro environment. Of solid cancers 20% are already hot so Roswell is focused on the 80%.
Nice research group for nwbo to partner with.
The Roswell PR state NWBO is developing its DCVax platform to treat solid tumors- big big statement here.
Why is the deal only 2.5M and 4%. (4% may not be “cheap but reasonable based on what the parties contributed)
This deal was not just about these trials, it was about continued collaboration and the rights to 5 patent families.
That fact makes the deal not cheap for nwbo, it makes the deal really cheap.
So the deal is cheap/reasonable so why is that?
Because only nwbo can monetize the trials and do so cost effectively and Roswell cannot?
If the 5 patent families were excluded is it possible Roswell would have had to pay nwbo and license the DC platform in order to monetize these trials?
So I think that’s it- if you need the DC platform you can pay in IP, Cash or a combo of the 2.
Voting yes
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News